Clinical Trial Update: Controlling Rapid Atrial Fibrillation With Dexmedetomidine [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports results from Phase 2/3 studies evaluating dexmedetomidine for rapid atrial fibrillation and heart-rate control; the trial was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Stony Brook University | Conditions: Rapid Atrial Fibrillation, Heart Rate Control | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-06-04